Tratamiento farmacológico de la obesidad
Álvarez V., Verónica.
Rev. Méd. Clín. Condes
; 23(2): 173-179, Mar. 2012. ilus, tab, graf
Artigo em Espanhol | LILACS | ID: lil-707640
Appetite suppressants as adjuncts for weight loss.
The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction.
D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
Diethylpropion and mazindol: An end to the discussion?
Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial.
Weight loss medications--where do they fit in?
Necrotising vasculitis of the skin associated with an herbal medicine containing amfepramone.